Charles Schwab Investment Management Inc Amneal Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,082,814 shares of AMRX stock, worth $24.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,082,814
Previous 1,822,322
14.29%
Holding current value
$24.2 Million
Previous $14.7 Million
41.42%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
150MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA18MShares$209 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...